The consumer regulator has dragged Western Australia’s Quantum Housing and its sole director to court for allegedly engaging in unconscionable conduct and false, misleading or deceptive conduct in relation to a government-sponsored affordable housing program that incentivises below-market rentals.
Flight Centre has been hit with legal action on behalf of employees accusing the travel giant of short-changing its workers through commission-based payments.
Security guard union United Voice has lost a challenge to a ruling that found Wilson Security could legally allocate overtime to Sundays over a four-week roster to avoid paying penalty rates.
Nine Network has been ordered to pay a British tourist $100,000 in a defamation suit over a news broadcast that aired following his acquittal on assault charges related to a brawl with rugby player that used the term “coward punch” to describe the dust-up.
Energy drink giant Red Bull has won judgment against South Korea’s Bullsone in a battle over the auto parts company’s Australian trade mark for a leaping red and black bull.
The Australian Securities and Investments Commission has won its bid for a court order placing Melbourne-based forex trader Berndale Capital into receivership for allegedly failing to safeguard client money.
Qantas has failed in its bid to appeal a decision by the Fair Work Commission to allow a terminated employee’s late unfair dismissal application to proceed because the worker’s solicitor was to blame for the delay.
Two units of private equity company Antin Infrastructure Partners have taken their legal battle with Spain to Australian court, filing a lawsuit to enforce a $161 million arbitration award related to investments the companies made in two solar plants in southern Spain.
Building products supplier Wagners has taken its largest cement customer, Boral, to court in a dispute over pricing, and will take a $10 million hit to its 2019 earnings as a result.
After losing its fight for a temporary injunction, Sanofi-Aventis has dropped its patent lawsuit against Alphapharm over the generic drug maker’s plans to market a competing insulin injector pen in Australia.